A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study

Lam, Marnix; Garin, Etienne; Maccauro, Marco; Kappadath, S.; Sze, Daniel; Turkmen, Cüneyt; Cantasdemir, Murat; Haste, Paul; Herrmann, Ken; Alsuhaibani, Hamad; Dreher, Matthew; Fowers, Kirk; Salem, Riad

doi:10.1007/s00259-022-05774-0

A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study

Atıf İçin Kopyala

Lam M., Garin E., Maccauro M., Kappadath S. C., Sze D. Y., Turkmen C., ...Daha Fazla

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, cilt.49, sa.10, ss.3340-3352, 2022 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 49 Sayı: 10
Basım Tarihi: 2022
Doi Numarası: 10.1007/s00259-022-05774-0
Dergi Adı: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Biotechnology Research Abstracts, CINAHL, EMBASE, MEDLINE
Sayfa Sayıları: ss.3340-3352
Anahtar Kelimeler: Radioembolization, Yttrium-90, Dosimetry, Hepatocellular carcinoma, MULTICENTER, SURVIVAL
İstanbul Üniversitesi Adresli: Evet

Özet

Purpose To investigate the relationships between tumor absorbed dose (TAD) or normal tissue absorbed dose (NTAD) and clinical outcomes in hepatocellular carcinoma (HCC) treated with yttrium-90 glass microspheres.